default author photo

Xiaobing Wang

China Pharmaceutical University - State Key Laboratory of Natural Medicines

SCHOLARLY PAPERS

1

DOWNLOADS

50

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Discovery of Dual PARP and CDK6 Inhibitors for Triple-Negative Breast Cancer with Wild-Type BRCA

Number of pages: 50 Posted: 26 Oct 2022
Cheng Wang, Xinye Chen, Yonglei Zhang, Dehua Lu, Xingchen Liu, Fucheng Yin, Shang Li, Lingyi Kong and Xiaobing Wang
China Pharmaceutical University, China Pharmaceutical University, China Pharmaceutical University, China Pharmaceutical University, China Pharmaceutical University, China Pharmaceutical University, China Pharmaceutical University, China Pharmaceutical University and China Pharmaceutical University - State Key Laboratory of Natural Medicines
Downloads 50 (1,109,210)

Abstract:

Loading...

Triple-Negative Breast Cancer, Breast cancer susceptibility gene 1/2, Poly(ADP-ribose) polymerase, Synthetic lethality, Cyclin-dependent kinases 6